Verde Science, Inc. Stock price

Equities

VRCI

US92337L2034

Biotechnology & Medical Research

Market Closed - OTC Markets 02:10:42 2024-03-22 pm EDT 5-day change 1st Jan Change
0.000001 USD 0.00% Intraday chart for Verde Science, Inc. 0.00% 0.00%
Sales 2013 - Sales 2014 - Capitalization 655K
Net income 2013 - Net income 2014 -2M EV / Sales 2013 -
Net Debt 2013 252K Net Debt 2014 259K EV / Sales 2014 -
P/E ratio 2013
-9.91 x
P/E ratio 2014
-0.23 x
Employees 1
Yield 2013 *
-
Yield 2014
-
Free-Float 90.01%
More Fundamentals * Assessed data
Dynamic Chart
1 year
0.00
Extreme 0
0.00
3 years
0.00
Extreme 0
0.00
5 years
0.00
Extreme 0
0.01
10 years
0.00
Extreme 0
32.20
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 07-01-30
Director/Board Member 61 -
Members of the board TitleAgeSince
Director/Board Member 61 -
Chief Executive Officer 58 07-01-30
More insiders
Date Price Change Volume

Delayed Quote OTC Markets, March 22, 2024 at 02:10 pm EDT

More quotes
Verde Science, Inc. is a pharmaceutical research and development company. The Company is engaged in medical science consulting business. The Company is focused on the discovery of drugs and treatment modalities, as well as diagnostic devices and pharmaceutical delivery systems for the treatment of diseases and medical issues. The Company is focused on developing medicinal formulations from cannabinoids and tetrahydrocannabinol (THC) compounds for the treatment of various issues, such as migraines, glaucoma, loss of appetite from cancer therapies, and other medical issues. The Company is focused on launching its THC Pharmaceutical Development Program by executing a research program, which involves developing formulations preparing protocols for clinical trials.
More about the company
  1. Stock
  2. Equities
  3. Stock Verde Science, Inc. - OTC Markets